STERIS (NYSE:STE – Get Free Report) issued an update on its FY25 earnings guidance on Tuesday morning. The company provided EPS guidance of $9.05-$9.25 for the period, compared to the consensus EPS estimate of $9.15.
STERIS Stock Performance
Shares of NYSE STE traded up $1.37 during mid-day trading on Tuesday, reaching $239.27. 844,912 shares of the company were exchanged, compared to its average volume of 487,674. The company’s 50-day simple moving average is $224.64 and its 200-day simple moving average is $222.69. The company has a quick ratio of 2.36, a current ratio of 3.08 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $23.65 billion, a P/E ratio of 62.64 and a beta of 0.83. STERIS has a twelve month low of $195.47 and a twelve month high of $243.19.
STERIS (NYSE:STE – Get Free Report) last posted its earnings results on Wednesday, May 8th. The medical equipment provider reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.41 by $0.17. The company had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.41 billion. STERIS had a net margin of 6.95% and a return on equity of 13.73%. STERIS’s quarterly revenue was up 10.8% compared to the same quarter last year. During the same quarter last year, the company posted $2.30 EPS. As a group, research analysts predict that STERIS will post 9.16 earnings per share for the current year.
STERIS Increases Dividend
Analyst Ratings Changes
STE has been the subject of several analyst reports. Piper Sandler reiterated a neutral rating and issued a $225.00 price objective (up previously from $220.00) on shares of STERIS in a research note on Friday, May 10th. JMP Securities reiterated a market outperform rating and issued a $265.00 price objective on shares of STERIS in a research note on Friday, July 26th. StockNews.com cut shares of STERIS from a buy rating to a hold rating in a research note on Monday. Finally, Needham & Company LLC reiterated a hold rating on shares of STERIS in a research note on Friday, May 10th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of Hold and an average price target of $241.60.
Check Out Our Latest Research Report on STE
Insider Activity
In other news, Director Jacqueline B. Kosecoff sold 4,584 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $231.53, for a total value of $1,061,333.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, SVP Cary L. Majors sold 2,024 shares of STERIS stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $232.13, for a total transaction of $469,831.12. Following the sale, the senior vice president now directly owns 11,369 shares of the company’s stock, valued at approximately $2,639,085.97. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jacqueline B. Kosecoff sold 4,584 shares of STERIS stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $231.53, for a total transaction of $1,061,333.52. The disclosure for this sale can be found here. In the last ninety days, insiders sold 7,762 shares of company stock worth $1,798,477. 1.14% of the stock is currently owned by corporate insiders.
STERIS Company Profile
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
See Also
- Five stocks we like better than STERIS
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Uber’s Earnings Beat: Rideshare and Delivery Surge
- What is the Nikkei 225 index?
- Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Cloudflare Stock Flares Up on Solid EPS Beat and Raised Guidance
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.